| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AMERISOURCEBERGEN CORP | 53,000 | 4,281,340 | 0.68% | ||
| 52 | CARDINAL HEALTH INC | 55,000 | 4,273,500 | 0.68% | ||
| 53 | MACROGENICS INC | 140,000 | 4,187,400 | 0.67% | ||
| 54 | MCKESSON CORP | 25,000 | 4,168,750 | 0.66% | ||
| 55 | LABORATORY CORP AMER HLDGS | 30,000 | 4,124,400 | 0.66% | ||
| 56 | RADIUS HEALTH INCORPORATED COM NEW | 75,000 | 4,056,750 | 0.64% | ||
| 57 | THERMO FISHER SCIENTIFIC INC | 25,000 | 3,976,500 | 0.63% | ||
| 58 | CEMPRA INC | 161,000 | 3,896,200 | 0.62% | ||
| 59 | ARRAY BIOPHARMA INC | 550,000 | 3,712,500 | 0.59% | ||
| 60 | UNIVERSAL HLTH SVCS INC | 30,000 | 3,696,600 | 0.59% | ||
| 61 | DAVITA INC | 55,000 | 3,633,850 | 0.58% | ||
| 62 | NXSTAGE MED INC COM | 145,300 | 3,631,047 | 0.58% | ||
| 63 | COOPER COS INC | 20,000 | 3,585,200 | 0.57% | ||
| 64 | COHERUS BIOSCIENCES INC COM | 131,357 | 3,517,740 | 0.56% | ||
| 65 | REVANCE THERAPEUTICS INC COM | 210,000 | 3,404,100 | 0.54% | ||
| 66 | PERRIGO CO PLC | 35,000 | 3,231,550 | 0.51% | ||
| 67 | DYNAVAX TECHNOLOGIES CORP | 300,000 | 3,147,000 | 0.50% | ||
| 68 | CHIMERIX INC | 550,000 | 3,047,000 | 0.48% | ||
| 69 | HALOZYME THERAPEUTICS INC | 250,000 | 3,020,000 | 0.48% | ||
| 70 | PORTOLA PHARMACEUTICALS INC | 120,805 | 2,743,482 | 0.44% | ||
| 71 | NEURODERM LTD | 144,546 | 2,672,656 | 0.42% | ||
| 72 | KERYX BIOPHARMACEUTICALS INCORPORATED | 500,111 | 2,655,589 | 0.42% | ||
| 73 | INSULET CORPORATION | 57,000 | 2,333,580 | 0.37% | ||
| 74 | RITE AID CORP | 300,000 | 2,307,000 | 0.37% | ||
| 75 | TESARO INCORPORATED | 21,500 | 2,155,160 | 0.34% | ||
| 76 | ACHILLION PHARMACEUTICALS IN | 266,000 | 2,154,600 | 0.34% | ||
| 77 | FIBROGEN INC | 104,000 | 2,152,800 | 0.34% | ||
| 78 | ADAMAS PHARMACEUTICALS INC | 130,000 | 2,133,300 | 0.34% | ||
| 79 | INTRA-CELLULAR THERAPIES INC | 135,000 | 2,057,400 | 0.33% | ||
| 80 | NEUROCRINE BIOSCIE COM USD0.001 | 40,000 | 2,025,600 | 0.32% | ||
| 81 | Esperion Therapeutics Inc | 130,000 | 1,800,500 | 0.29% | ||
| 82 | TANDEM DIABETES CARE INC COM | 234,000 | 1,792,440 | 0.28% | ||
| 83 | JOHNSON & JOHNSON | 15,000 | 1,771,950 | 0.28% | ||
| 84 | INTERCEPT PHARMACEUTICALS INCORPORATED | 10,000 | 1,645,900 | 0.26% | ||
| 85 | ACADIA PHARMACEUTICALS INC COM | 50,000 | 1,590,500 | 0.25% | ||
| 86 | VALEANT PHARMACEUTICALS INTL | 50,000 | 1,227,500 | 0.19% | ||
| 87 | TETRAPHASE PHARMACEUTICALS INC COM | 300,000 | 1,149,000 | 0.18% | ||
| 88 | REGULUS THERAPEUTICS INC COM | 300,000 | 990,000 | 0.16% | ||
| 89 | ANTHERA PHARMACEUTICALS I | 300,000 | 945,000 | 0.15% | ||
| 90 | ADVERUM BIOTECHNOLOGIES INC | 154,006 | 632,965 | 0.10% | ||
| 91 | Catabasis Pharmaceuticals Inc | 100,000 | 616,000 | 0.10% | ||
| 92 | MEDNAX INC | 9,000 | 596,250 | 0.09% | ||
| 93 | OREXIGEN THERAPEUTICS INC | 120,000 | 398,400 | 0.06% | ||
| 94 | MIRATI THERAPEUTICS INC COM | 50,000 | 330,500 | 0.05% | ||
| 95 | CONCERT PHARMACEUTICALS INCORPORATED | 30,099 | 304,301 | 0.05% | ||
| 96 | OCULAR THERAPEUTIX INC | 40,000 | 274,800 | 0.04% | ||
| 97 | WELLS FARGO & CO NEW | 4,522 | 200,234 | 0.03% | ||
| 98 | QUALCOMM INC | 2,869 | 196,526 | 0.03% | ||
| 99 | CATERPILLAR INC | 2,178 | 193,341 | 0.03% | ||
| 100 | GLAUKOS CORP | 5,100 | 192,474 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001415889-16-007347, filed 2016.11.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
